Immunadd Immunadd
  • Technology
    • Our Pipeline
    • Our Adjuvants
    • Our Patent
  • News & Events
  • About
    • ImmunAdd at a Glance
    • Our Founder and CEO
    • Our Philosophy
  • Contact
default-logo
  • Home
  • Technology
    • Our Pipeline
    • Our Adjuvants
    • Our Patent
  • News & Events
  • About
    • ImmunAdd at a Glance
    • Our Founder and CEO
    • Our Philosophy
  • Contact
  • 繁中
News
_ 2024-10-23

The Israel Patent Office Has Granted ImmunAdd a Patent for “SAPONIN CONJUGATE AND VACCINE OR PHARMACEUTICAL COMPOSITION COMPRISING THE SAME”

TAIPEI, Taiwan Oct. 23, 2024 – The Israel Patent Office has granted ImmunAdd the patent on saponin conjugate and vaccine or pharmaceutical composition comprising the same. “Innovation for Better Health” We are ImmunAdd.

LEARN MORE
News
_ 2024-10-23

China National Intellectual Property Administration Has Granted ImmunAdd a Patent for “SAPONIN CONJUGATE AND VACCINE OR PHARMACEUTICAL COMPOSITION COMPRISING THE SAME”

TAIPEI, Taiwan Oct. 23, 2024 – China National Intellectual Property Administration has granted ImmunAdd the patent on saponin conjugate and vaccine or pharmaceutical composition comprising the same. “Innovation for Better Health” We are ImmunAdd.

LEARN MORE

Home

Technology

Our Pipeline

Our Adjuvants

Our Patent

About

Immunadd at a Glance

Our Founder and CEO

Our Philosophy

News&Event

Contact

Office:

11 F.-8, No. 130, Sec. 2, Zhongxiao E. Rd., Zhongzheng Dist., Taipei City 100411, Taiwan (R.O.C.)

© 2024 immunadd. All rights reserved.